Can Stuart Therapeutics’ ST-100 heal damaged corneas? A new FDA filing opens a critical test
Stuart Therapeutics files an FDA amendment for ST-100 corneal wound trials, with collagen repair evidence and 2027 milestones in focus.
Medical Devices & Diagnostics